Events

Business Law | Intellectual Property Law

Webinar: IP Issues in M&A Transactions

This program is part of a collaboration between the IP Law Section and the Business Law Section, where we select a topic where or on which IP and business law attorneys work together, such as M&A transactions, and pair practitioners from each section to present on the topic.

Business Law

Webinar: Gaps, Traps & Mishaps: Ethics for Non-Litigators

1 Hour MCLE; 1 Legal Ethics Today’s transactional lawyers perform a whole host of legal and other services for their clients. It can run the gamut from conceptualizing to strategizing and then on to the drafting, crafting and negotiating these often times complex, risky, and often times bespoke transactions their clients bring to the table.…

Business Law

Webinar: Are You and Your Clients Paying Enough Attention to Cyber-Risk?

 Awareness Over Knowledge: Equip yourself to converse effectively with your clients about the intricacies of cyber risk. While deep technical knowledge might not be required to have a meaningful discussion with a client, having a heightened sense of awareness of the issues is indispensable.

Business Law

Webinar: What’s In Your Wallet? – Crypto in the Bankruptcy Courts

Reorganization under bankruptcy Chapter 11 is presently the only U.S. legal regime to resolve the failures of cryptocurrency platforms.  Among the high-profile crypto Chapter 11 cases in the last two years were Celsius and BlockFi.  To sort out unprecedented issues in those cases over the ownership of custodial and depository customers’ accounts, bankruptcy courts played unique roles in the unregulated and largely uninsured space of crypto exchanges.  This program’s panel will feature the insights of battle-tested legal counsel in those cases, as well as a discussion of new crypto risks that may find themselves in the bankruptcy courts. Participants will learn how to properly advise their clients of the risks in holding digital assets.

Business Law | California Lawyers Association

Free Webinar: Purdue Pharma: The U.S. Supreme Court’s Opinion and Its Ramifications

On June 27, 2024, in a 5-4 decision in Harrington v. Purdue Pharma L.P., the U.S. Supreme Court held that the Bankruptcy Code “does not authorize a release and injunction that, as part of a plan of reorganization under Chapter 11, effectively seeks to discharge claims against a nondebtor without the consent of affected claimants.” The Supreme Court thereby rejected the cornerstone of a chapter 11 plan and nationwide mass tort settlement, allegedly worth about $10 billion, involving OxyContin maker Purdue Pharma and members of the Sackler family. This was the most significant bankruptcy decision in decades. The Purdue Pharma case delineates the outer boundaries of the Bankruptcy Code as a solution to mass tort litigation and the so-called collective action problem. Although the decision prohibits nonconsensual third-party releases in a chapter 11 plan, several types of non-debtor releases remain available after Purdue Pharma. The majority and dissenting opinions both have significant implications for bankruptcy law and legal advocacy in pending and future proceedings.

We are committed to accessibility! Virtual events are equipped with closed captioning. To request an in-person accommodation, send us a note at accessibility@calawyers.org or contact us at 916-516-1760 for assistance.

Forgot Password

Enter the email associated with you account. You will then receive a link in your inbox to reset your password.

Personal Information

Select Section(s)

CLA Membership is $99 and includes one section. Additional sections are $99 each.

Payment